Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Radiology

Retrieve available abstracts of 81 articles:
HTML format

Single Articles

    December 2021
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.

    November 2021
  2. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    PubMed     Abstract available

  3. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    PubMed     Abstract available

  4. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    PubMed     Abstract available

    October 2021
  5. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
    Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
    Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
    PubMed     Abstract available

    Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
    Radiology. 2021;301:163-165.

  7. SOULEN MC, Garcia-Monaco R
    Closing the Gap in Curative Ablation of Liver Cancer.
    Radiology. 2021;301:237-238.

    September 2021
    Detection of Tumor Thrombus in Hepatocellular Carcinoma.
    Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.

  9. BAE JS, Lee JM, Jeon SK, Yoo J, et al
    LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
    Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
    PubMed     Abstract available

  10. YU MM, Tang XL, Jin H, Yang S, et al
    Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
    PubMed     Abstract available

  11. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    PubMed     Abstract available

    August 2021
  12. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    PubMed     Abstract available

  13. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    PubMed     Abstract available

    July 2021
  14. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    PubMed     Abstract available

  15. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    PubMed     Abstract available

  16. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.

  17. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    PubMed     Abstract available

    June 2021
  18. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    PubMed     Abstract available

  19. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.

    May 2021
  20. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    PubMed     Abstract available

  21. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.

  22. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    PubMed     Abstract available

  23. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    PubMed     Abstract available

    April 2021
  24. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    PubMed     Abstract available

  25. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    PubMed     Abstract available

  26. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    PubMed     Abstract available

    March 2021
  27. O'SHEA A, Pierce TT
    US Elastography in Hepatic Fibrosis-Radiology In Training.
    Radiology. 2021 Mar 23:203893. doi: 10.1148/radiol.2021203893.
    PubMed     Abstract available

  28. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    PubMed     Abstract available

  29. BAE JS, Lee JM, Yoon JH, Kang HJ, et al
    Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Radiology. 2021 Mar 2:203537. doi: 10.1148/radiol.2021203537.
    PubMed     Abstract available

  30. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.

    February 2021
    LI-RADS Version 2018 Is of Limited Use in the Diagnosis of Hepatocellular Carcinoma in Children.
    Radiology. 2021 Feb 23:204480. doi: 10.1148/radiol.2021204480.

  32. KHANNA G, Chavhan GB, Schooler GR, Fraum TJ, et al
    Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
    Radiology. 2021 Feb 23:203559. doi: 10.1148/radiol.2021203559.
    PubMed     Abstract available

  33. NARDELLI S, Riggio O, Turco L, Gioia S, et al
    Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
    Radiology. 2021 Feb 2:203051. doi: 10.1148/radiol.2021203051.
    PubMed     Abstract available

    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.

    January 2021
    Normal Fetal Umbilical, Portal, and Hepatic Venous System: Four-dimensional STIC Rendering.
    Radiology. 2021 Jan 26:203300. doi: 10.1148/radiol.2021203300.
    PubMed     Abstract available

  36. MADOFF DC, Cornman-Homonoff J, Fortune BE, Gaba RC, et al
    Management of Refractory Ascites Due to Portal Hypertension: Current Status.
    Radiology. 2021 Jan 26:201960. doi: 10.1148/radiol.2021201960.
    PubMed     Abstract available

  37. CHEN S, Peng Z, Zhang Y, Chen M, et al
    Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Radiology. 2021 Jan 19:202289. doi: 10.1148/radiol.2021202289.
    PubMed     Abstract available

  38. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    PubMed     Abstract available

  39. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.

  40. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    PubMed     Abstract available

    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.

  42. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    PubMed     Abstract available

  43. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    PubMed     Abstract available

    December 2020
  44. EISENBREY JR, Forsberg F, Wessner CE, Delaney LJ, et al
    US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.
    Radiology. 2020 Dec 15:202321. doi: 10.1148/radiol.2020202321.
    PubMed     Abstract available

    November 2020
  45. ROSTAMBEIGI N, Farsad K, Young S, Shrestha P, et al
    Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study.
    Radiology. 2020 Nov 17:201690. doi: 10.1148/radiol.2020201690.
    PubMed     Abstract available

  46. GUPTA I, Eisenbrey JR, Machado P, Stanczak M, et al
    Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.
    Radiology. 2020 Nov 17:202677. doi: 10.1148/radiol.2020202677.
    PubMed     Abstract available

  47. FRULIO N, Balabaud C, Trillaud H, Bioulac-Sage P, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Nov 10:203244. doi: 10.1148/radiol.2020203244.

  48. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.

    October 2020
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.

    Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
    Radiology. 2020 Oct 6:203631. doi: 10.1148/radiol.2020203631.

  51. NAKAI Y, Gonoi W, Kurokawa R, Nishioka Y, et al
    MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis.
    Radiology. 2020 Oct 6:202367. doi: 10.1148/radiol.2020202367.
    PubMed     Abstract available

  52. DAVARPANAH AH, Eberhardt LW
    Case 282: Fishbone Pylephlebitis.
    Radiology. 2020;297:239-243.
    PubMed     Abstract available

  53. DE ROOS A, Lamb HJ
    Exploring the Interaction between Liver and Heart Disease.
    Radiology. 2020;297:62-63.

  54. WEISS CR, Nezami N
    One Step Closer to Precision Medicine for Transarterial Therapy of HCC.
    Radiology. 2020;297:235-236.

    September 2020
  55. TANG A
    Using MRI to Assess Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:203376. doi: 10.1148/radiol.2020203376.

  56. WANG F, Numata K, Ruan L
    Accurate Assessment of Vascularity of Focal Hepatic Lesions in Arterial Phase Imaging.
    Radiology. 2020 Sep 29:202780. doi: 10.1148/radiol.2020202780.

  57. MIN JH, Lee MW, Park HS, Lee DH, et al
    Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:201940. doi: 10.1148/radiol.2020201940.
    PubMed     Abstract available

  58. DO RK, Mendiratta-Lala M
    Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.
    Radiology. 2020;296:562-563.

  59. SOFOCLEOUS CT, Vasiniotis Kamarinos N
    Tumor Radiation-absorbed Dose: The Missing Link in Radioembolization.
    Radiology. 2020;296:685-686.

    August 2020
  60. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 25:209017. doi: 10.1148/radiol.2020209017.

  61. ISAAK A, Praktiknjo M, Jansen C, Faron A, et al
    Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis.
    Radiology. 2020 Aug 18:201057. doi: 10.1148/radiol.2020201057.
    PubMed     Abstract available

  62. ZIV E, Zhang Y, Kelly L, Nikolovski I, et al
    NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.
    Radiology. 2020 Aug 11:200201. doi: 10.1148/radiol.2020200201.
    PubMed     Abstract available

  63. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 4:200115. doi: 10.1148/radiol.2020200115.
    PubMed     Abstract available

  64. KIM TK, Jang HJ
    Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
    Radiology. 2020 Aug 4:202763. doi: 10.1148/radiol.2020202763.

    July 2020
  65. PARK S, Joo I, Lee DH, Bae JS, et al
    Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Radiology. 2020 Jul 21:192797. doi: 10.1148/radiol.2020192797.
    PubMed     Abstract available

  66. SAVIC LJ, Doemel LA, Schobert IT, Montgomery RR, et al
    Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
    Radiology. 2020 Jul 7:200373. doi: 10.1148/radiol.2020200373.
    PubMed     Abstract available

    June 2020
  67. SCHOOLER GR, Squires JH, Alazraki A, Chavhan GB, et al
    Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
    Radiology. 2020 Jun 30:200751. doi: 10.1148/radiol.2020200751.
    PubMed     Abstract available

  68. HERMANN AL, Dieudonne A, Ronot M, Sanchez M, et al
    Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with (90)Y in the SARAH Study.
    Radiology. 2020 Jun 30:191606. doi: 10.1148/radiol.2020191606.
    PubMed     Abstract available

  69. SUGIMOTO K, Moriyasu F, Oshiro H, Takeuchi H, et al
    The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Jun 23:192665. doi: 10.1148/radiol.2020192665.
    PubMed     Abstract available

  70. BARR RG, Wilson SR, Rubens D, Garcia-Tsao G, et al
    Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement.
    Radiology. 2020 Jun 9:192437. doi: 10.1148/radiol.2020192437.
    PubMed     Abstract available

    Treat or Wait? Hepatobiliary Phase Hypointense Nodule without Arterial Phase Hyperenhancement.
    Radiology. 2020 Jun 2:201726. doi: 10.1148/radiol.2020201726.

  72. JOO I, Kim SY, Kang TW, Kim YK, et al
    Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Radiology. 2020 Jun 2:192275. doi: 10.1148/radiol.2020192275.
    PubMed     Abstract available

    May 2020
  73. GIORGIO A, De Luca M, Gatti P, Matteucci P, et al
    CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies.
    Radiology. 2020 May 12:200623. doi: 10.1148/radiol.2020200623.

  74. LOCKHART ME, Smith AD
    Fatty Liver Disease: Artificial Intelligence Takes on the Challenge.
    Radiology. 2020;295:351-352.

    April 2020
  75. ZHOU IY, Clavijo Jordan V, Rotile NJ, Akam E, et al
    Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Apr 28:192118. doi: 10.1148/radiol.2020192118.
    PubMed     Abstract available

    March 2020
  76. MULE S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, et al
    Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230.
    PubMed     Abstract available

    February 2020
  77. HAN A, Byra M, Heba E, Andre MP, et al
    Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Radiology. 2020 Feb 25:191160. doi: 10.1148/radiol.2020191160.
    PubMed     Abstract available

  78. KONO Y, Sirlin CB, Fetzer DT, Kim TK, et al
    Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US.
    Radiology. 2020 Feb 18:192557. doi: 10.1148/radiol.2020192557.

  79. KROMREY ML, Le Bihan D, Ichikawa S, Motosugi U, et al
    Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
    Radiology. 2020 Feb 11:191498. doi: 10.1148/radiol.2020191498.
    PubMed     Abstract available

  80. DO RK, Mendiratta-Lala M
    LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating.
    Radiology. 2020;294:327-328.

    November 2019
  81. BASTATI N, Beer L, Mandorfer M, Poetter-Lang S, et al
    Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Radiology. 2019 Nov 19:190734. doi: 10.1148/radiol.2019190734.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.